Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FOXP3 regulating long intergenic non-coding RNA (FLICR) is a long non-coding RNA located in close proximity to the Foxp3 gene and specifically expressed in mature regulatory T cells (Tregs)[1][2][4]. It acts as a negative regulator of Foxp3 expression, fine-tuning the amount of FoxP3 protein and thereby modulating Treg function and peripheral immune tolerance[1][4]. FLICR acts in cis, altering chromatin accessibility at conserved regions of the Foxp3 locus without affecting DNA methylation[1][4]. Its expression is particularly significant in conditions of low IL-2, with IL-2 signaling acting to repress FLICR[1][4]. Increased FLICR activity reduces Foxp3 and Treg suppressive activity, promoting susceptibility to autoimmune diseases such as type 1 diabetes, while diminished FLICR augments immune suppression and may impair anti-viral or anti-tumor responses[1][4]. FLICR is one of several lncRNAs that add a regulatory layer to Treg biology and immune homeostasis, but is not a protein, enzyme, or classical therapeutic target[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FOXP3 regulating long intergenic non-coding RNA (FLICR).